Leukemic transformation in patients with myeloproliferative neoplasms: a population-based retrospective study.
This study determined the epidemiology of developing leukemic transformation in patients with myeloproliferative neoplasms (MPN). We utilized the Surveillance, Epidemiology and End Results 13 database to identify 83 cases of leukemic transformation in MPN (n = 9335). The 5-year cumulative incidence of leukemic transformation was higher in male versus female (2.17 vs 1.09%; p < 0.001), and in myelofibrosis (2.19%; 95% CI: 1.36-3.34%), compared with essential thrombocythemia (0.37%; 95% CI: 0.19-0.65%) and polycythemia vera (0.72%; 95% CI: 0.46-1.07%; p < 0.001). Patients had a median survival of 2 months after leukemic transformation, worse in older patients and without any impact of prior MPN subtypes. Myelofibrosis has a higher risk of leukemic transformation. Overall survival is dismal regardless of MPN subtypes.